awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Triples
Insights
Schema
BETA
Class frequency
Class hierarchy
SPARQL
Graphs
1
Q38132693-21C43A01-9A9D-4EC0-A185-E87E852820BA
Q38132693-21C43A01-9A9D-4EC0-A185-E87E852820BA
BestRank
Statement
http://www.wikidata.org/entity/statement/Q38132693-21C43A01-9A9D-4EC0-A185-E87E852820BA
Bevacizumab in advanced NSCLC: chemotherapy partners and duration of use.
P2860
Q38132693-21C43A01-9A9D-4EC0-A185-E87E852820BA
BestRank
Statement
http://www.wikidata.org/entity/statement/Q38132693-21C43A01-9A9D-4EC0-A185-E87E852820BA
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
31a4a01092340210538f42ea56e821fc0d66eaa1
P2860
Phase II trial of pemetrexed plus bevacizumab for second-line therapy of patients with advanced non-small-cell lung cancer: NCCTG and SWOG study N0426.